Login with HarvardKey to view all events.

Event Dates

Monday, May 17, 2021 1pm to 5pm

Virtual Event
Add to calendar

Cancer immunotherapy has emerged as a major component of cancer treatment. This symposium aims to catalyze new approaches to anti-cancer immunity in settings where it is currently limited by bringing together bioengineers, cancer immunologists and oncologists.

Featured Topics:

Mechanisms of Protective Tumor Immunity
Glenn Dranoff, M.D.
Novartis

Single-cell Sequencing of T Cells in Food Allergy
J. Christopher Love, Ph.D.
Massachusetts Institute of Technology

Moving Forward CAR T Cell Therapies for Multiple Myeloma and Beyond
Eric Smith, M.D., Ph.D.
Dana-Farber Cancer Institute

Immunotherapeutic Drug Delivery to Lymph Nodes Augments Cancer Immunotherapy
Susan Thomas, Ph.D.
Georgia Tech

Molecular Understanding of T Cell Exhaustion and Role in Disease
E. John Wherry, Ph.D.
Perelman School of Medicine, University of Pennsylvania

Sponsored by the Harvard i3 Center, a part of NIH’s Cancer Moonshot initiative that was formed to accelerate cancer research to make more therapies available to more patients, while also improving the ability to prevent cancer and detect it at an early stage.

Additional supporters include:
Harvard John A. Paulson School of Engineering and Applied Sciences
Massachusetts General Hospital
Harvard Department of Stem Cell and Regenerative Biology
Dana-Farber Cancer Institute
Wyss Institute for Biologically Inspired Engineering at Harvard University

1 person is interested in this event

User Activity

No recent activity